Chemical Imaging of Platinum-Based Drugs and their Metabolites

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Xin ^a   Hummon, Amanda B ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DIETHYLDITHIOCARBAMIC ACID; DRUG; OXALIPLATIN; PLATINUM; PLATINUM COMPLEX;

CHEMISTRY; CULTURE MEDIUM; HCT 116 CELL LINE; HUMAN; LIQUID CHROMATOGRAPHY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; METABOLOME; MULTICELLULAR SPHEROID; PATHOLOGY; TANDEM MASS SPECTROMETRY; THERMOTHERAPY; THREE DIMENSIONAL IMAGING; TIME FACTOR;

CARBOPLATIN; CHROMATOGRAPHY, LIQUID; CISPLATIN; CULTURE MEDIA; DITIOCARB; HCT116 CELLS; HUMANS; HYPERTHERMIA, INDUCED; IMAGING, THREE-DIMENSIONAL; METABOLOME; ORGANOPLATINUM COMPOUNDS; PHARMACEUTICAL PREPARATIONS; PLATINUM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPHEROIDS, CELLULAR; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 85002968664     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38507     Document Type: Article

References (40)

1. Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nature Reviews Cancer 7(8), 573-584 (2007).
2. Molenaar, C., Teuben, J. M., Heetebrij, R. J., Tanke, H. J. & Reedijk, J. New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy. JBIC Journal of Biological Inorganic Chemistry 5(5), 655-665 (2000).
3. Kalayda, G. V. et al. Dinuclear platinum complexes with N, N′-bis (aminoalkyl)-1, 4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance. JBIC Journal of Biological Inorganic Chemistry 9(4), 414-422 (2004).
4. Zhang, J. Z. et al. Getting to the core of platinum drug bio-distributions: The penetration of anti-cancer platinum complexes into spheroid tumour models. Metallomics 4(11), 1209-1217 (2012).
5. Alderden, R. A. et al. Elemental tomography of cancer-cell spheroids reveals incomplete uptake of both platinum (II) and platinum (IV) complexes. Journal of the American Chemical Society 129(44), 13400-13401 (2007).
6. Theiner, S. et al. LA-ICP-MS imaging in multicellular tumor spheroids-A novel tool in the preclinical development of metal-based anticancer drugs. Metallomics 8(4), 398-402 (2016).
7. Bianga, J. et al. Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor. Metallomics 6(8), 1382-1386 (2014).
8. Schreiber-Brynzak, E. et al. Behavior of platinum (iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation. Metallomics 8(4), 422-433 (2016).
9. Legin, A. A. et al. NanoSIMS combined with fluorescence microscopy as a tool for subcellular imaging of isotopically labeled platinum-based anticancer drugs. Chemical Science 5(8), 3135-3143 (2014).
10. Bouslimani, A., Bec, N., Glueckmann, M., Hirtz, C. & Larroque, C. Matrix-Assisted laser desorption/ionization imaging mass spectrometry of oxaliplatin derivatives in heated intraoperative chemotherapy (HIPEC)-like treated rat kidney. Rapid Communications in Mass Spectrometry 24(4), 415-421 (2010).
11. Egger, A. E. et al. Quantitative bioimaging by LA-ICP-MS: A methodological study on the distribution of Pt and Ru in viscera originating from cisplatin-And KP1339-Treated mice. Metallomics 6(9), 1616-1625 (2014).
12. Moreno-Gordaliza, E. et al. Elemental Bioimaging in Kidney by LA-ICP-MS As a Tool to Study Nephrotoxicity and Renal Protective Strategies in Cisplatin Therapies. Analytical chemistry 83(20), 7933-7940 (2011).
13. Nilsson, A. et al. Mass spectrometry imaging in drug development. Analytical chemistry 87(3), 1437-1455 (2015).
14. Drummer, O. H., Proudfoot, A., Howes, L. & Louis, W. J. High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric method. Clinica chimica acta 136(1), 65-74 (1984).
15. Theile, D. et al. Cellular pharmacokinetic/pharmacodynamic relationship of platinum cytostatics in head and neck squamous cell carcinoma evaluated by liquid chromatography coupled to tandem mass spectrometry. Journal of Pharmacology and Experimental Therapeutics 341(1), 51-58 (2012).
16. Osawa, T. et al. Validated method using liquid chromatography-electrospray ionization tandem mass spectrometry for the determination of contamination of the exterior surface of vials containing platinum anticancer drugs. Talanta 85(3), 1614-1620 (2011).
17. Tang, C. et al. Quantitative determination of platinum derived from cisplatin in human plasma ultrafiltrate using derivatization with diethyldithiocarbamate and liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Analytical Methods 5(24), 7117-7126 (2013).
18. Minakata, K. et al. MALDI-Q-TOF mass spectrometric determination of gold and platinum in tissues using their diethyldithiocarbamate chelate complexes. Analytical and bioanalytical chemistry 406(5), 1331-1338 (2014).
19. Esquivel, J. et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement. Annals of surgical oncology 14(1), 128-133 (2007).
20. Hompes, D. et al. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: A Belgian multicentre prospective phase II clinical study. Annals of surgical oncology 19(7), 2186-2194 (2012).
21. de Bree, E., Witkamp, A. J. & Zoetmulder, F. A. Intraperitoneal chemotherapy for colorectal cancer. Journal of surgical oncology 79(1), 46-61 (2002).
22. Issels, R. D. Hyperthermia adds to chemotherapy. European Journal of Cancer 44(17), 2546-2554 (2008).
23. Cox, M. C., Reese, L. M., Bickford, L. R. & Verbridge, S. S. Toward the broad adoption of 3D tumor models in the cancer drug pipeline. ACS Biomaterials Science & Engineering 1(10), 877-894 (2015).
24. Liu, X. & Hummon, A. B. Mass Spectrometry Imaging of Therapeutics from Animal Models to Three-Dimensional Cell Cultures. Analytical chemistry 87(19), 9508-9519 (2015).
25. Liu, X., Weaver, E. M. & Hummon, A. B. Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry. Analytical chemistry 85(13), 6295-6302 (2013).
26. Li, H. & Hummon, A. B. Imaging mass spectrometry of three-dimensional cell culture systems. Analytical chemistry 83(22), 8794-8801 (2011).
27. Liu, X. & Hummon, A. B. Quantitative Determination of Irinotecan and the Metabolite SN-38 by Nanoflow Liquid Chromatography-Tandem Mass Spectrometry in Different Regions of Multicellular Tumor Spheroids. Journal of The American Society for Mass Spectrometry 26(4), 577-586 (2015).
28. Jerremalm, E., Wallin, I. & Ehrsson, H. New insights into the biotransformation and pharmacokinetics of oxaliplatin. Journal of pharmaceutical sciences 98(11), 3879-3885 (2009).
29. Luo, F. R., Wyrick, S. D. & Chaney, S. G. Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells. Oncology research 10(11-12), 595-603 (1997).
30. Mehmood, R. K. et al. Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective. World Journal of Oncology 5(3), 97-108 (2014).
31. Jerremalm, E., Wallin, I., Yachnin, J. & Ehrsson, H. Oxaliplatin degradation in the presence of important biological sulphurcontaining compounds and plasma ultrafiltrate. European journal of pharmaceutical sciences 28(4), 278-283 (2006).
32. Dedon, P. C. & Borch, R. F. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfurcontaining nucleophiles. Biochemical pharmacology 36(12), 1955-1964 (1987).
33. Soldatović, T. & Bugarčić, Ž. D. Study of the reactions between platinum (II) complexes and l-methionine in the presence and absence of 5′-GMP. Journal of inorganic biochemistry 99(7), 1472-1479 (2005).
34. Murdoch, P. S. L-Methionine increases the rate of reaction of 5′-guanosine monophosphate with the anticancer drug cisplatin: mixed-ligand adducts and reversible methionine binding. Journal of the Chemical Society Dalton Transactions 22, 3721-3726 (1995).
35. Strickmann, D. B., Kung, A. & Keppler, B. K. Application of capillary electrophoresis-mass spectrometry for the investigation of the binding behavior of oxaliplatin to 5′-GMP in the presence of the sulfur-containing amino acid L-methionine. Electrophoresis 23(1), 74-80 (2002).
36. Zhang, J. Z. et al. The use of spectroscopic imaging and mapping techniques in the characterisation and study of DLD-1 cell spheroid tumour models. Integrative Biology 4(9), 1072-1080 (2012).
37. Ishikawa, T., Li, Z. S., Lu, Y. P. & Rea, P. A. The GS-X pump in plant, yeast, and animal cells: structure, function, and gene expression. Bioscience reports 17(2), 189-207 (1997).
38. Klein, O. et al. MALDI imaging mass spectrometry: discrimination of pathophysiological regions in traumatized skeletal muscle by characteristic peptide signatures. Proteomics 14(20), 2249-2260 (2014).
39. Fatfat, M. et al. Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species. BMC cancer 14(1), 527 (2014).
40. Denoyer, D., Masaldan, S., La Fontaine, S. & Cater, M. A. Targeting copper in cancer therapy: Copper That Cancer. Metallomics 7(11), 1459-1476 (2015).